Breaking News

PSI CRO Appoints Regulatory Affairs Head

By Kristin Brooks | February 26, 2014

Schmoetzer brings extensive industry experience

Dr. Gabriele Schmoetzer has been appointed head of regulatory affairs, Germany, at PSI CRO. Dr. Schmoetzer will supervise all regulatory-related activities for Germany, Austria and Switzerland.
 
Dr. Schmoetzer brings 24 years of clinical research experience, having worked for small, mid-size and large CROs. She has held positions in international and global project management, regulatory affairs, where she has held managerial positions, and has been responsible for clinical trial submissions in Germany and a number of other EU countries. Dr. Schmoetzer has experience with RA-specific processes and brings both technical expertise and extensive knowledge of the clinical trial regulatory environment.

Related Compliance:

  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks